quinolinic acid has been researched along with cyclin d1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chuang, DM; Qian, Y; Qin, ZH; Senatorov, VV; Wang, Y; Wei, H; Wei, W | 1 |
Chase, TN; Chen, RW; Chuang, DM; Li, LY; Liang, ZQ; Qin, ZH; Wang, X; Wang, Y | 1 |
2 other study(ies) available for quinolinic acid and cyclin d1
Article | Year |
---|---|
Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease.
Topics: Animals; Antimanic Agents; Benzazepines; Cell Death; Cyclin D1; Disease Models, Animal; Dopamine Antagonists; Glutamate Decarboxylase; Huntington Disease; Immunohistochemistry; In Situ Nick-End Labeling; Isoenzymes; Lithium; Lithium Chloride; Male; Neostriatum; Neurons; Neuroprotective Agents; Neurotoxins; Quinolinic Acid; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; RNA, Messenger | 2001 |
Nuclear factor-kappaB-dependent cyclin D1 induction and DNA replication associated with N-methyl-D-aspartate receptor-mediated apoptosis in rat striatum.
Topics: Analysis of Variance; Animals; Apoptosis; Bromodeoxyuridine; Corpus Striatum; Cyclin D1; Cyclin-Dependent Kinase 4; DNA Replication; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Functional Laterality; In Situ Nick-End Labeling; Neurons; NF-kappa B; Peptides; Phosphopyruvate Hydratase; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2007 |